Senior executive and angel investor in Healthcare and Life Sciences
Mark Dearden is a seasoned International executive with 30-year operating experience in Life Sciences. Mark is known for his commitment to fostering collaboration and driving impactful outcomes, which are underpinned by his passion for science and innovation.
Having initially joined LGC group to lead and incubate a start-up venture in 2011, Mark Dearden went on to serve as Vice President of Strategy and Marketing for the Genomics Division. In this role, Mark was responsible for the Division’s M&A activities, partnering, organic product development and marketing communications activities. Mark was appointed as Managing Director of the Genomics Division in July 2020, steering the organisation to significant growth whilst navigating Brexit, COVID and challenging macro market conditions.
Prior to LGC, Mark has held diverse International leadership positions in General Management, Marketing, Product Management and Sales with leading life sciences companies such as GE Healthcare and Thermo Scientific. Mark has a BSc (honours) from University of Sydney and an MBA from Warwick Business School.
